LABORATORY RESEARCH USE ONLY NOT FOR HUMAN OR VETERINARY USE
PEP YOUR PEPRUO
PepYourPep Tirzepatide 60 mg vial mockup with emerald cap and holographic silver label
Packaging illustration · Final appearance may vary

THE RESEARCH COLLECTION

Tirzepatide 60 mg

SKU PYP-TIRZ-60

PepYourPep Tirzepatide 60 mg is a research material listing for studies of dual GIP and GLP-1 receptor activity. These hormone-signaling pathways are relevant to glucose regulation, appetite and energy balance.

For laboratory research use only. Not for human or veterinary use.

$160.00USD · Listed product price
Verified Test 1 batch report(s) ↗
For laboratory research use only.

Not for human or veterinary use.

Product overview

PepYourPep Tirzepatide 60 mg is a research material listing for studies of dual GIP and GLP-1 receptor activity. These hormone-signaling pathways are relevant to glucose regulation, appetite and energy balance.

Potential benefits studied in research

These are research findings and areas of investigation, not established health benefits of this product. For laboratory research use only; not for human or veterinary use.

  • Glucose-regulation research: investigated for glucose-dependent insulin secretion and glucose tolerance.
  • Appetite and body-weight research: published studies examine changes in food intake and body weight with characterized study material.
  • Dual-pathway comparisons: enables investigation of combined GIP/GLP-1 activity versus single-receptor signaling.

Published clinical findings concern the tested medicinal formulations and study conditions. They do not establish this research vial as equivalent to a prescription medicine.

About Tirzepatide 60 mg

This listing is the 60 mg size in the PepYourPep research collection. Tirzepatide, also known in research literature as LY3298176, is a single peptide that activates the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is studied in the context of incretin biology and metabolic signaling.

Research background

Published receptor studies report different signaling characteristics at the two targets. At the GLP-1 receptor, researchers have examined a preference for cyclic AMP signaling relative to beta-arrestin recruitment and differences in receptor internalization. These findings make receptor response, signaling bias and comparisons with individual receptor agonists relevant research topics.

Results depend on the experimental model and material tested. Literature about tirzepatide is not a certificate for this vial and does not demonstrate that a research material is equivalent to a regulated finished medicine.

Understanding the 60 mg size

The milligram amount identifies the listed material quantity, not a concentration or an administration instruction. Final fill details and material form must be checked against the supplied product specification.

Quality and batch documentation

Review the batch identifier, identity testing, analytical method and certificate of analysis in Verified Test when available. No batch COA or purity percentage is currently published for this listing. A general research citation is not batch testing.

Storage and laboratory handling

Product-specific storage temperature, shelf life, solvent compatibility and physical form are awaiting supplier documentation. Consult the material-specific specification and safety data sheet before laboratory handling. No reconstitution or administration instructions are provided.

Intended use

For laboratory research use only. Not for human or veterinary use. The vial image is a packaging illustration; final packaging and supplied material must match the confirmed specification.

Scientific references

KEEP EXPLORING

More from the collection

GLP-3KLOW 80 mgMOTS-C 40 mgBlue Glutathione 1200 mg